Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhuogang Liu

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 1, 2020
Peripheral Absolute Lymphocyte Count: An Economical and Clinical Available Immune-Related Prognostic Marker for Newly Diagnosed Multiple MyelomaYing Yang, Zhuogang Liu, Hongtao Wang
American Journal of Translational Research|December 14, 2020
FBN1 promotes DLBCL cell migration by activating the Wnt/β-catenin signaling pathway and regulating TIMP1Hongtao Wang, Zhuogang Liu, Guojun Zhang
Journal of Cellular and Molecular Medicine|May 25, 2022
Expression of PD-L1 on regulatory B cells in patients with acute myeloid leukaemia and its effect on prognosisYingqing Shi, Zhuogang Liu, Hongtao Wang
American Journal of Translational Research|October 15, 2021
CDC45 modulates MCM7 expression and inhibits cell proliferation by suppressing the PI3K/AKT pathway in acute myeloid leukemiaRong Zhang, Zhuogang Liu, Guojun Zhang
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 25, 2019
The Role of Regulatory B Cells in Patients with Acute Myeloid LeukemiaYing Lv, Hongtao Wang, Zhuogang Liu
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 16, 2013
Scytonemin inhibits cell proliferation and arrests cell cycle through downregulating Plk1 activity in multiple myeloma cellsGuojun Zhang, Zhe Zhang, Zhuogang Liu
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 16, 2013
Polo-like kinase 1 is overexpressed in renal cancer and participates in the proliferation and invasion of renal cancer cellsGuojun Zhang, Zhe Zhang, Zhuogang Liu
Molecular and Cellular Biochemistry|April 14, 2017
Hypomethylation agent decitabine restores drug sensitivity by depressing P-glycoprotein activity through MAPK signaling pathwayHuihan Wang, Xiaobin Wang, Aijun Liao, et al.
Frontiers in Oncology|June 28, 2021
HLA-E Binding Peptide as a Potential Therapeutic Candidate for High-Risk Multiple MyelomaYing Yang, Zhuogang Liu, Hongtao Wang, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|May 1, 2019
Skp2 inhibitor SKPin C1 decreased viability and proliferation of multiple myeloma cells and induced apoptosisYing Yang, Wei Yan, Zhuogang Liu, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|August 1, 2020
Peripheral Absolute Lymphocyte Count: An Economical and Clinical Available Immune-Related Prognostic Marker for Newly Diagnosed Multiple MyelomaYing Yang, Zhuogang Liu, Hongtao Wang
American Journal of Translational Research|December 14, 2020
FBN1 promotes DLBCL cell migration by activating the Wnt/β-catenin signaling pathway and regulating TIMP1Hongtao Wang, Zhuogang Liu, Guojun Zhang
Journal of Cellular and Molecular Medicine|May 25, 2022
Expression of PD-L1 on regulatory B cells in patients with acute myeloid leukaemia and its effect on prognosisYingqing Shi, Zhuogang Liu, Hongtao Wang
American Journal of Translational Research|October 15, 2021
CDC45 modulates MCM7 expression and inhibits cell proliferation by suppressing the PI3K/AKT pathway in acute myeloid leukemiaRong Zhang, Zhuogang Liu, Guojun Zhang
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 25, 2019
The Role of Regulatory B Cells in Patients with Acute Myeloid LeukemiaYing Lv, Hongtao Wang, Zhuogang Liu
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 16, 2013
Scytonemin inhibits cell proliferation and arrests cell cycle through downregulating Plk1 activity in multiple myeloma cellsGuojun Zhang, Zhe Zhang, Zhuogang Liu
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 16, 2013
Polo-like kinase 1 is overexpressed in renal cancer and participates in the proliferation and invasion of renal cancer cellsGuojun Zhang, Zhe Zhang, Zhuogang Liu
Molecular and Cellular Biochemistry|April 14, 2017
Hypomethylation agent decitabine restores drug sensitivity by depressing P-glycoprotein activity through MAPK signaling pathwayHuihan Wang, Xiaobin Wang, Aijun Liao, et al.
Frontiers in Oncology|June 28, 2021
HLA-E Binding Peptide as a Potential Therapeutic Candidate for High-Risk Multiple MyelomaYing Yang, Zhuogang Liu, Hongtao Wang, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|May 1, 2019
Skp2 inhibitor SKPin C1 decreased viability and proliferation of multiple myeloma cells and induced apoptosisYing Yang, Wei Yan, Zhuogang Liu, et al.
Pageof 7